NCT06080100

Brief Summary

The goal of this clinical trial is to propose for implementation and evaluate the effectiveness of xenon sedation for the relief of psychoemotional stress disorder before the operation of refractive laser vision correction patients with high anxiety and stress instability who underwent xenon analgosedation before refractive laser vision correction. The main question\[s\] it aims to answer are:

  1. 1.To develop a method of xenon sedation in patients with a high level of psychoemotional stress before surgery - refractive laser vision correction.
  2. 2.To evaluate the effect of inhaled xenon anesthesia in a sub-narcotic dose on the duration of surgery, satisfaction of surgeons and patients with anesthesia, the level of postoperative pain in patients in comparison with anxiolytics.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Nov 2023

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 12, 2023

Completed
20 days until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

June 27, 2025

Status Verified

June 1, 2025

Enrollment Period

2.2 years

First QC Date

October 1, 2023

Last Update Submit

June 24, 2025

Conditions

Keywords

sedationlaser refractive interventionsanxietyxenon

Outcome Measures

Primary Outcomes (4)

  • the concentration of cortisol in the blood

    the change in the cortisol concentration index as a stress marker during xenon sedation before refractive laser vision correction operations in comparison with anxiolytics of the non-benzodiazepine series.

    30 minutes before surgery and 30 minutes after surgery

  • glucose concentration in capillary blood

    changes in glucose concentration index as a stress marker during xenon sedation before refractive laser vision correction operations in comparison with anxiolytics of the non-benzodiazepine series.

    30 minutes before surgery and 30 minutes after surgery

  • stress index

    the change in the heart rate variability measured by the Varikard device in comparison with the anxiolytics of the non-benzodiazepine series in the studied groups of patients.

    30 minutes before surgery and 30 minutes after surgery

  • rhythm index

    the change in the rhythm index measured by the Cardiovisor device in comparison with benzodiazepine-type anxiolytics in the studied groups of patients.

    30 minutes before surgery and 30 minutes after surgery

Study Arms (2)

Main group

ACTIVE COMPARATOR

patients with high anxiety and stress instability who underwent xenon analgosedation before refractive laser vision correction

Drug: Xenon

Control group

OTHER

patients with high anxiety and stress instability who underwent local anesthesia using standard premedication with hydroxyzine (hydroxyzine) 25 mg.

Other: premedication hydroxyzine 25 mg

Interventions

XenonDRUG

inhalation of xenon in a sub-narcotic dosage

Main group

taking anxiolytic 30 minutes before surgery

Control group

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • upcoming operation ReLEx® SMILE;
  • high anxiety and stress instability (Spielberger-Khanin test of 46 points or more);
  • signed informed consent to participate in the study.

You may not qualify if:

  • \- concomitant somatic diseases in the decompensation stage.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

s. Fyodorov Eye Microsurgery Federal State Inctitution

Krasnodar, 350012, Russia

RECRUITING

Related Publications (8)

  • Duygu Yalinbas, Erman Bozali, Ayla Uzun Çiçek. Comparison of Self-Esteem and Social Anxiety Levels of Adolescents Who Wear Spectacles and Who Do Not. Turkish Journal of Family Medicine & Primary Care.2021; 15(4):862-871. https://doi.org/10.21763/tjfmpc.976914

    BACKGROUND
  • Nazari R, Ahmadzadeh R, Mohammadi S, Rafiei Kiasari J. Effects of hand massage on anxiety in patients undergoing ophthalmology surgery using local anesthesia. J Caring Sci. 2012 Aug 25;1(3):129-34. doi: 10.5681/jcs.2012.019. eCollection 2012 Sep.

    PMID: 25276687BACKGROUND
  • Hou H, Li X, Song Y, Ji Y, Sun M, Wang D, Jiao J, Qu J, Gu H. Effect of interactive, multimedia-based home-initiated education on preoperative anxiety inchildren and their parents: a single-center randomized controlled trial. BMC Anesthesiol. 2023 Mar 28;23(1):95. doi: 10.1186/s12871-023-02055-7.

    PMID: 36977985BACKGROUND
  • Hatam Boustani, Sirus Pakseresht, Mitra Zamani, Mohammad Akmali. The effect of music therapy on the anxiety level of patients undergoing LASIK eye surgery before operation. Minerva Medica. 2018. 5(7): 80-87. https://doi.org/10.23736/S0394-9508.17.04756-8

    BACKGROUND
  • Sasajima H, Zako M, Ueta Y, Murotani K. Effects of Low-Concentration Nitrous Oxide Anesthesia on Patient Anxiety During Cataract Surgery: A Retrospective Cohort Study. Clin Ophthalmol. 2022 Aug 24;16:2803-2812. doi: 10.2147/OPTH.S382476. eCollection 2022.

    PMID: 36042911BACKGROUND
  • Shah R. History and Results; Indications and Contraindications of SMILE Compared With LASIK. Asia Pac J Ophthalmol (Phila). 2019 Sep-Oct;8(5):371-376. doi: 10.1097/01.APO.0000580132.98159.fa.

    PMID: 31567264BACKGROUND
  • Ganesh S, Brar S, Arra RR. Refractive lenticule extraction small incision lenticule extraction: A new refractive surgery paradigm. Indian J Ophthalmol. 2018 Jan;66(1):10-19. doi: 10.4103/ijo.IJO_761_17.

    PMID: 29283117BACKGROUND
  • Xia Y, Fang H, Xu J, Jia C, Tao G, Yu B. Clinical efficacy of xenon versus propofol: A systematic review and meta-analysis. Medicine (Baltimore). 2018 May;97(20):e10758. doi: 10.1097/MD.0000000000010758.

    PMID: 29768360BACKGROUND

MeSH Terms

Conditions

Stress, PsychologicalAnxiety Disorders

Interventions

Xenon

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

Noble GasesElementsInorganic ChemicalsGases

Study Officials

  • Sergey Sakhnov

    Director

    STUDY DIRECTOR

Central Study Contacts

Alexandr Romanov

CONTACT

Viktoria Myasnikova

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: According to the latest data, the need for xenon analgosedation occurs in 10% of cases from all excimer laser operations. N= 1,96\*10\*90/25=70.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
anesthesiologist

Study Record Dates

First Submitted

October 1, 2023

First Posted

October 12, 2023

Study Start

November 1, 2023

Primary Completion

January 1, 2026

Study Completion

April 1, 2026

Last Updated

June 27, 2025

Record last verified: 2025-06

Locations